In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Claudia Demarta-Gatsi *Global Health R&D of Merck Healthcare, Ares Trading S.A. (a subsidiary of Merck KGaA, Darmstadt, Germany), Eysins, Switzerland.ORCID 0000-0002-9610-2962 Julia S Wallner *Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Satish K Dhingra *Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York, New York, USA.
Sunil K Narwal *Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0001-5476-9753 Vandana Thathy *Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0001-7797-8638 Mohamed MaigaFaculty of Pharmacy, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Parasites and Microbes Research and Training Centre (PMRTC), Bamako, Mali.
Alhassane B DialloFaculty of Pharmacy, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Parasites and Microbes Research and Training Centre (PMRTC), Bamako, Mali.
Maike BonsenCentre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Emilie MathisLPHI, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Ana Rita GomesLPHI, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Matthias JacobsMerck KGaA, Darmstadt, Germany.
Matthias RottmannDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0002-2207-7899 Laurent DembeleFaculty of Pharmacy, Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Parasites and Microbes Research and Training Centre (PMRTC), Bamako, Mali.ORCID 0000-0001-9087-8439 David A FidockDepartment of Microbiology & Immunology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0001-6753-8938 Thomas SpangenbergGlobal Health R&D of Merck Healthcare, Ares Trading S.A. (a subsidiary of Merck KGaA, Darmstadt, Germany), Eysins, Switzerland.ORCID 0000-0002-5654-8919 Funding
Agence Nationale de la Recherche ANR-16-IDEX-0006Chica and Heinz Schaller FoundationEuropean Research Council 101117745healthcare business of Merck KGaA, Darmstadt, Germany 10.13039/100009945
6 · The paper itselfAbstract
Detailing the mode-of-action of novel antimalarial drugs is important to predict and optimize their treatment efficacy. To complement standardized
Indexed as
AminoquinolinesAntimalarialsPlasmodium falciparumAnimalsErythrocytesHumansPeptide Elongation Factor 2Protein BiosynthesisAminoquinolinesAntimalarialsPeptide Elongation Factor 2cabamiquinelive cell imagingluminescenceMitoTrackerpharmacodynamicsPlasmodium
Identifiers
PMID42714380
PMCPMC13689320
What OpenQuestion holds
Textmetadata
Read underepoch 390